Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local cold vs warmth for bruising after subcutaneous enoxaparin
IRCT2014040917197N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of enoxaparin in Disorder of skin and subcutaneous tissue (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Size of bruising at injection site. Started Apr 2014; status: completed.
02
Drugs
enoxaparin
03
Conditions
Disorder of skin and subcutaneous tissue
Beyond the preview
Go deeper on IRCT2014040917197N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014040917197N1.